MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
DarioHealth Corp. ROE Ratio 2011-2026 | DRIO
Annual ROE Ratio DarioHealth Corp.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -102.21 | -77.74 | -89.73 | -104.6 | -93.87 | -199.47 | -399.47 | 166.44 | -919.18 | 507.37 | 16128.29 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16128.29 | -919.18 | 1346.89 |
Quarterly ROE Ratio DarioHealth Corp.
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -67.86 | -74.97 | -74.66 | -50.27 | -73.39 | -75.44 | -76.59 | -62.08 | -79.66 | -74.11 | -71.05 | -49.6 | -71.09 | -75.01 | -71.96 | -49.86 | -73.13 | -74.91 | -74.1 | -72.64 | -87.48 | -79.06 | -93.32 | -71.78 | -117.31 | -147.99 | -184.91 | -143.64 | -543.11 | -897.05 | -1231.11 | -1198.4 | -1031.96 | -466.05 | 99.86 | 499.33 | 951.35 | 1236.94 | 1522.52 | 1356.08 | 1599.27 | 1390.43 | 1181.6 | 729.58 | 16928.41 | 32884.06 | 48839.7 | 48596.51 | 49128.44 | 33461.54 | 17794.63 | 1595.79 | 1595.79 | 1063.86 | 531.93 | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 49128.44 | -1231.11 | 4641.86 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
22.45 | $ 119.04 | - | $ 36.2 B |  USA |
 |
Anixa Biosciences
ANIX
|
-72.07 | $ 2.83 | - | $ 91.8 K | USA |
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 23.54 | - | $ 247 M |  China |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 27.57 | - | $ 766 M | USA |
 |
Celcuity
CELC
|
-96.68 | $ 107.4 | - | $ 4.24 B | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 13.79 | - | $ 417 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 175.69 | - | $ 8.71 B | USA |
 |
IDEXX Laboratories
IDXX
|
65.99 | $ 635.54 | - | $ 51.1 B | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 129.56 | - | $ 20.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 282.99 | - | $ 23.5 B | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 78.84 | - | $ 5.32 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K |  Israel |
|
Biodesix
BDSX
|
-205.65 | $ 15.5 | - | $ 2.01 B | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 316.71 | - | $ 27.1 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 5.29 | - | $ 490 M | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 9.54 | - | $ 1.22 B | USA |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.12 | - | $ 1.42 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 208.36 | - | $ 23.1 B | USA |
 |
National Research Corporation
NRC
|
63.26 | $ 13.39 | - | $ 329 M | USA |
 |
Danaher Corporation
DHR
|
6.88 | $ 204.01 | - | $ 145 B | USA |
 |
Organovo Holdings
ONVO
|
-23.71 | - | -2.3 % | $ 19.4 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | $ 103.37 | - | $ 19.5 B | USA |
 |
OPKO Health
OPK
|
1.03 | $ 1.19 | - | $ 826 M | USA |
 |
Bioventus
BVS
|
-90.0 | $ 8.74 | - | $ 548 M | USA |
 |
Pacific Biosciences of California
PACB
|
-10214.54 | $ 1.52 | - | $ 456 M | USA |
 |
DexCom
DXCM
|
30.46 | $ 73.08 | - | $ 28.5 B | USA |
 |
PerkinElmer
PKI
|
3.33 | - | -0.91 % | $ 14.7 B | USA |
 |
Psychemedics Corporation
PMD
|
-62.26 | - | -1.84 % | $ 15.3 M | USA |
 |
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B |  Niderland |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 108.7 | - | $ 8.97 B |  Irlanda |
 |
Quotient Limited
QTNT
|
312.05 | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Precipio
PRPO
|
-40.56 | $ 24.98 | 1.2 % | $ 32.4 M | USA |
 |
Renalytix AI plc
RNLX
|
425.97 | - | 5.66 % | $ 22.7 M | Britain |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 18.8 | - | $ 1 B | USA |
 |
Senseonics Holdings
SENS
|
-113.21 | $ 6.83 | - | $ 285 M | USA |